Serotonin and superior mesenteric artery resistance index

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 66, Issue 5, 2006, Pages 395-406

  Hansen, Mark Bensen ^a,b   Arif, F ^a   Wallin, L ^a   Pedersen, J F ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

5 hydroxytryptamine; Blood flow; Doppler ultrasound; Human; Physiology; Resistance index; Serotonin; Superior mesenteric artery

Indexed keywords

SEROTONIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTERY BLOOD FLOW; ARTERY RESISTANCE; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART RATE; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN EXPERIMENT; HYPERSEROTONINEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SEROTONINERGIC SYSTEM; SUPERIOR MESENTERIC ARTERY;

ADULT; AGED; BLOOD PLATELETS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MESENTERIC ARTERY, SUPERIOR; MIDDLE AGED; SEROTONIN;

EID: 33747117621     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510600763301     Document Type: Article

References (44)

1. Hansen MB, Dresner LS, Wait RB. Profile of neurohumoral agents on mesenteric and intestinal blood flow in health and disease. Physiol Res 1998;47:307-27.
2. Da Prada M, Tranzer JP, Pletscher A. Storage of 5-hydroxytryptamine in human blood platelets. Experientia 1972;28:1328-9.
3. Kalkman HO, Engel G, Hoyer D. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats. J Hypertens 1984;Suppl 2:S143-5.
4. Bearcroft CP, Perrett D, Farthing MJ. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study. Gut 1998;42:42-6.
5. Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003;52:663-70.
6. Atkinson W, Lockhart SJ, Whorwell P, Keevil BG, Houghton LA. Altered 5-hydroxytryptamine signaling in patients with constipation and diarrhoea predominant irritable bowel syndrome. Gastroenterology 2006;130:34-43.
7. Hansen MB. The enteric nervous system III: a target for pharmacological treatment. Pharmacol Toxicol 2003;93:1-13.
8. Van Zwieten PA. Pathophysiological relevance of serotonin. J Cardiovasc Pharmacol 1987;10 Suppl 3:S19-25.
9. Friedel D, Thomas R, Fisher RS. Ischemic colitis during treatment with alosetron. Gastroenterology 2001;120:557-60.
10. Mayer EA, Bradesi S. Alosetron and irritable bowel syndrome. Expert Opin Pharmacother 2003;4:2089-98.
11. Siegel S, Castellan NJ. Nonparametric statistics for the behavioural sciences. Boston: McGraw-Hill; 1988. pp 216-22.
12. Sieber C, Beglinger C, Jager K, Stalder GA. Intestinal phase of superior mesenteric artery blood flow in man. Gut 1992;33:497-501.
13. Andersen TC, Pedersen JF, Nordentoft T, Olsen O. Fat and mesenteric blood flow. Scand. J Gastroenterol 1999;34:894-7.
14. Perko MJ. Duplex ultrasound for assessment of superior mesenteric artery blood flow. Eur J Vasc Endovasc Surg 2001;21:106-17.
15. Lynch TG, Hobson RW, Kerr JC, Brousseau DA, Silverman DG, Reilly CA, et al. Doppler ultrasound, laser Doppler, and perfusion fluorometry in bowel ischemia. Arch Surg 1988;123:483-6.
16. Schmidt PT, Lordal M, Gazelius B, Hellstrom PM. Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans. Gut 2003;52:53-6.
17. Zoli M, Merkel C, Sabba C, Sacerdoti D, Gaiani S, Ferraioli G, et al. Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery. J Ultrasound Med 1996;15:99-106.
18. Spencer JA, Giussani DA, Moore PJ, Hanson MA. In vitro validation of Doppler indices using blood and water. J Ultrasound Med 1991;10:305-8.
19. Maulik D, Arbeille P, Kadado T. Hemodynamic foundation of umbilical arterial Doppler waveform analysis. Biol Neonate 1992;62:280-9.
20. Fenger-Gron J, Mulvany MJ, Christensen KL. Intestinal blood flow is controlled by both feed arteries and microcirculatory resistance vessels in freely moving rats. J Physiol 1997;498:215-24.
21. Vanner S, MacNaughton WK. Submucosal secretomotor and vasodilator reflexes. Neurogastroenterol Motil 2004;16:39-43.
22. Sieber C, Beglinger C, Jaeger K, Hildebrand P, Stalder GA. Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex. Gut 1991;32:361-6.
23. Lordal M, Hellstrom PM. 5-Hydroxytryptamine: initiator of phase 3 of migrating motor complex. Acta Physiol Scand 1995;155:241-2.
24. Banks RO, Gallavan RH Jr, Zinner MH, Bulkley GB, Harper SL, Granger DN, et al. Vasoactive agents in control of the mesenteric circulation. Fed Proc 1985;44:2743-9.
25. Granger ND, Kvietys PR, Korthuis RJ, Premen AJ. Microcirculation of the intestinal mucosa. In: Schultz SG, editor. Handbook of physiology The gastrointestinal system. Bethesda, Maryland, USA: American Physiological Society; 1989. pp 1405-74.
26. Jodal M, Lundgren O. Neurohormonal control of gastrointestinal blood flow. In: Schultz SG, editor. Handbook of physiology. The gastrointestinal system Bethesda. Maryland, USA: American Physiological Society; 1989. pp 1617-71.
27. Tsukamoto Y, Goto H, Hase S, Arisawa T, Ohara A, Suzuki T, et al. Serotonin-induced decrease of duodenal mucosal blood flow plus acid load produces duodenal mucosal lesion in rats. Digestion 1991;50:99-103.
28. Fara JW. Mesenteric vasodilator effect of 5-hydroxytryptamine: possible enteric neuron mediation. Arch Int Pharmacodyn Ther 1976;221:235-49.
29. Fasth S, Hedlund H, Hulten L, Nordgren S, Oresland T. The effects of 5-hydroxytryptamine on large intestinal motility and blood flow in the cat. Acta Physiol Scand 1983;118:329-36.
30. Anderson GM, Stevenson JM, Cohen DJ. Steady-state model for plasma free and platelet serotonin in man. Life Sci 1987;41:1777-85.
31. Zinner MJ, Kasher F, Jaffe BM. The hemodynamic effects of intravenous infusions of serotonin in conscious dogs. J Surg Res 1983;34:171-8.
32. Rossi P, Andriesse GI, Oey PL, Wieneke GH, Roelofs JM, Akkermans LM. Stomach distension increases efferent muscle sympathetic nerve activity and blood pressure in healthy humans. J Neurol Sci 1998;161:148-55.
33. O'Donovan D, Feinle C, Tonkin A, Horowitz M, Jones KL. Postprandial hypotension in response to duodenal glucose delivery in healthy older subjects. J Physiol 2002;540:673-9.
34. Boeckxstaens GE, Hirsch DP, van den Elzen BD, Heisterkamp SH, Tytgat GN. Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function. Gastroenterology 2001;121:1054-63.
35. Martin GR. Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol Ther 1994;62:283-324.
36. Su C, Uruno T. Excitatory and inhibitory effects of 5-hydroxytryptamine in mesenteric arteries of spontaneously hypertensive rats. Eur J Pharmacol 1984;106:283-90.
37. Gronstad KO, Dahlstrom A, Jaffe BM, Ahlman H. Regional and selective changes in blood flow of the feline small intestine induced by endoluminal serotonin. Acta Physiol Scand 1986;127:207-13.
38. Coates MD, Mahoney CR, Linden DR, Sampson JE, Chen J, Blaszyk H, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004;126:1657-64.
39. Dunlop SP, Coleman NS, Blackshaw E, Perkins AC, Singh G, Marsden CA, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005;3:349-57.
40. Pata C, Erdal ME, Derici E, Yazar A, Kanik A, Ulu O. Serotonin transporter gene polymorphism in irritable bowel syndrome. Am J Gastroenterol 2002;97:1780-4.
41. Galligan JJ. 5-hydroxytryptamine, ulcerative colitis, and irritable bowel syndrome: molecular connections. Gastroenterology 2004;126:1897-9.
42. Hicks GA, Coldwell JR, Schindler M, Ward PA, Jenkins D, Lynn PA, et al. Excitation of rat colonic afferent fibres by 5-HT(3) receptors. J Physiol 2002;544:861-9.
43. Dalessandri KM, Lantz BM, Tsukamoto H, Link DP, Brock J. Superior mesenteric artery vasoactivity in hyperlipidemic Watanabe rabbits versus normal lipidemic New Zealand controls. J Invest Surg 1989;2:471-7.
44. Lopez JA, Brown BP, Armstrong ML, Piegors DJ, Heistad DD. Response of the mesenteric circulation to serotonin in normal and atherosclerotic monkeys: implications for the pathogenesis of non-occlusive intestinal ischaemia. Cardiovasc Res 1989;23:117-24.